Hyperfine (HYPR) Competitors $1.17 +0.05 (+4.46%) Closing price 04:00 PM EasternExtended Trading$1.15 -0.02 (-1.71%) As of 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HYPR vs. DCTH, SNWV, BFLY, RXST, CLPT, SMTI, NPCE, TCMD, BWAY, and SKINShould you be buying Hyperfine stock or one of its competitors? The main competitors of Hyperfine include Delcath Systems (DCTH), Sanuwave Health (SNWV), Butterfly Network (BFLY), RxSight (RXST), ClearPoint Neuro (CLPT), Sanara MedTech (SMTI), NeuroPace (NPCE), Tactile Systems Technology (TCMD), Brainsway (BWAY), and Beauty Health (SKIN). These companies are all part of the "medical equipment" industry. Hyperfine vs. Its Competitors Delcath Systems Sanuwave Health Butterfly Network RxSight ClearPoint Neuro Sanara MedTech NeuroPace Tactile Systems Technology Brainsway Beauty Health Hyperfine (NASDAQ:HYPR) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations. Is HYPR or DCTH more profitable? Delcath Systems has a net margin of 3.18% compared to Hyperfine's net margin of -364.54%. Delcath Systems' return on equity of 6.91% beat Hyperfine's return on equity.Company Net Margins Return on Equity Return on Assets Hyperfine-364.54% -84.82% -69.39% Delcath Systems 3.18%6.91%5.80% Does the media refer more to HYPR or DCTH? In the previous week, Delcath Systems had 4 more articles in the media than Hyperfine. MarketBeat recorded 6 mentions for Delcath Systems and 2 mentions for Hyperfine. Delcath Systems' average media sentiment score of 1.61 beat Hyperfine's score of 0.48 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hyperfine 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Delcath Systems 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do insiders & institutionals hold more shares of HYPR or DCTH? 15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 31.0% of Hyperfine shares are owned by company insiders. Comparatively, 17.4% of Delcath Systems shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate HYPR or DCTH? Hyperfine presently has a consensus price target of $1.28, suggesting a potential upside of 9.69%. Delcath Systems has a consensus price target of $24.50, suggesting a potential upside of 110.30%. Given Delcath Systems' stronger consensus rating and higher probable upside, analysts plainly believe Delcath Systems is more favorable than Hyperfine.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hyperfine 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, HYPR or DCTH? Hyperfine has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Which has higher valuation and earnings, HYPR or DCTH? Delcath Systems has higher revenue and earnings than Hyperfine. Hyperfine is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHyperfine$10.80M8.52-$40.72M-$0.52-2.25Delcath Systems$37.21M10.95-$26.39M$0.05233.00 SummaryDelcath Systems beats Hyperfine on 14 of the 16 factors compared between the two stocks. Get Hyperfine News Delivered to You Automatically Sign up to receive the latest news and ratings for HYPR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HYPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HYPR vs. The Competition Export to ExcelMetricHyperfineMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$91.94M$6.89B$5.78B$9.93BDividend YieldN/A1.22%6.67%4.52%P/E Ratio-2.2526.4775.6726.68Price / Sales8.5267.07553.74213.18Price / CashN/A21.6037.1158.92Price / Book1.754.9911.446.09Net Income-$40.72M$176.38M$3.28B$266.14M7 Day Performance-5.65%-0.04%0.84%0.27%1 Month Performance-2.50%3.51%7.15%4.13%1 Year Performance28.46%10.91%59.66%23.92% Hyperfine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HYPRHyperfine2.2234 of 5 stars$1.17+4.5%$1.28+9.7%+13.7%$91.94M$10.80M-2.25190DCTHDelcath Systems3.1516 of 5 stars$10.89-2.1%$24.50+125.0%+2.2%$388.99M$70.24M217.8060News CoveragePositive NewsSNWVSanuwave Health2.7734 of 5 stars$42.66-5.2%$55.00+28.9%N/A$385.56M$32.63M-5.1740News CoverageAnalyst ForecastAnalyst RevisionBFLYButterfly Network3.3304 of 5 stars$1.56+2.3%$3.00+92.9%-1.0%$382.65M$82.06M-5.55460News CoverageRXSTRxSight2.3238 of 5 stars$8.61-7.2%$10.00+16.1%-84.3%$379.70M$139.93M-10.76220CLPTClearPoint Neuro1.8079 of 5 stars$10.50-1.9%$19.67+87.3%-11.1%$304.17M$31.39M-12.96110Positive NewsSMTISanara MedTech2.0985 of 5 stars$32.93-3.0%$50.00+51.8%-1.6%$302.23M$86.67M-28.3960NPCENeuroPace4.0562 of 5 stars$8.65-3.8%$16.60+91.9%+35.4%$297.40M$79.91M-10.30170Positive NewsGap DownTCMDTactile Systems Technology2.3324 of 5 stars$13.00-1.7%$13.50+3.8%+1.0%$294.92M$292.98M20.971,037Positive NewsBWAYBrainsway3.8072 of 5 stars$15.36+1.1%$18.00+17.2%+110.7%$287.31M$41.02M59.08120Positive NewsShort Interest ↓SKINBeauty Health1.7415 of 5 stars$2.10-5.0%$2.63+25.0%+2.6%$280.28M$334.30M-7.501,030 Related Companies and Tools Related Companies Delcath Systems Alternatives Sanuwave Health Alternatives Butterfly Network Alternatives RxSight Alternatives ClearPoint Neuro Alternatives Sanara MedTech Alternatives NeuroPace Alternatives Tactile Systems Technology Alternatives Brainsway Alternatives Beauty Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HYPR) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hyperfine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hyperfine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HYPR Stock Alerts